None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: A. Patients undergoing living donor liver transplantation between adults B. Male or female patients aged 19 to under 80 years old C. Patients who have received a thorough explanation of the purpose and details of the trial and have voluntarily agreed to participate in the study by signing a written consent form approved by the Institutional Review Board prior to participation in the trial D. Patients with South Korean nationality residing in the country who are available for a minimum of 2 years of follow-up after surgery
Exclusion criteria
Exclusion criteria: A. Re-transplant patients B. Multi-organ transplant patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Predicting the correlation between the incidence of bile duct complications and ICG FI within 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| A. Incidence of biliary complications 12 months post-transplant, B. Graft survival rate 12 months after transplantation, C. Patient survival rate 12 months post-transplant. | — |
Countries
Korea, Republic of
Contacts
Seoul National University Hospital